US Patent 7429612 Indoline compound and medicinal use thereof
Patent 7429612 was granted and assigned to Kyoto Pharmaceutical Industries on September, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Akihisa Yoshimi0
Hiroaki Shirahase0
Kenji Takahash0
Masayasu Kasai0
Miho Ikai0
Shouji Kamiya0
Tadatsugu Tarumi0
Edits on 14 Sep, 2023
Golden AI
Edits made to:
Article (+97 characters)
Article
Patent abstract
The present invention provides an indoline compound represented by the formula (I)
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07429612 Indoline compound and medicinal use thereof US Patent 7429612 Indoline compound and medicinal use thereof
Infobox
Patent Number
074296120
Patent Number
74296120
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074296120
Date of Patent
September 30, 2008
0Patent Application Number
105211750
Date Filed
July 16, 2003
0Official Website
Patent Primary Examiner
Edits on 14 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07429612 Indoline compound and medicinal use thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07429612
Date of patent
September 30, 2008
Patent application number
10521175
Date Filed
July 16, 2003
Patent primary examiner
Find more entities like US Patent 7429612 Indoline compound and medicinal use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.